COMMUNIQUÉS West-GlobeNewswire

DietDemand Explains How Diabetic Diets Can Go Hand-in-Hand with Weight Loss
19/04/2019
MONTGOMERY, Ala., April 19, 2019 (GLOBE NEWSWIRE) -- The weight gain epidemic in this day in age is based upon lots of factors such as a decreasing amount of physical activity, and stress. Yet, the main culprit has much [...]
Pixium Vision Reports Cash Position as of March 31, 2019
19/04/2019
Paris, France. April 19, 2019 – 7.00 AM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more [...]
Pixium Vision annonce sa situation de trésorerie au 31 mars 2019
19/04/2019
Paris, le 19 avril 2019 – 7h00 CEST– Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon [...]
IBA - Transparency notificaiton
19/04/2019
IBA – TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, April 18, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment [...]
IBA - Transparancy notification
19/04/2019
IBA – PUBLICATION RELATIVE À UNE NOTIFICATION TRANSPARENCE Louvain-la-Neuve, Belgique, 18 avril 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de [...]
Tetra Bio-Pharma Shareholders Approve the Acquisition of Panag Pharma
18/04/2019
Another Important Milestone Will be Achieved with the Closing of this Transaction OTTAWA, April 18, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the "Company" ) (TSX-V: TBP) (OTCQB: TBPMF), is pleased to [...]
Les actionnaires de Tetra Bio-Pharma approuvent l’acquisition de Panag Pharma
18/04/2019
Cette transaction marque un autre jalon important pour l’entreprise OTTAWA, 18 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « Société » ) (TSX-V : TBP) (OTCQB : TBPMF) est heureuse d’annoncer qu’ [...]
Helix BioPharma Corp. Closes First Tranche of Private Placement
18/04/2019
RICHMOND HILL, Ontario, April 18, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5%
18/04/2019
LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) [...]
T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date
18/04/2019
LEXINGTON, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced [...]
WW Schedules First Quarter 2019 Earnings Conference Call
18/04/2019
NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WTW) (“WW”) will release its results for the first quarter 2019 after market close on Thursday, May 2, 2019. WW will host a [...]
Sientra to Release First Quarter Financial Results on May 8, 2019
18/04/2019
SANTA BARBARA, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra” or the “Company”), announced today that the Company will release its first quarter 2019 [...]
Sol-Gel Technologies Announces Participation in Upcoming Investor Conference
18/04/2019
NESS ZIONA, Israel, April 18, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
18/04/2019
Results from final analysis of the composite primary endpoint were consistent with the futility analysis reported in April 2018 Results from post hoc analyses revealed a potential survival benefit with NEOD001 in the [...]
Aduro Biotech Appoints Experienced Financial Executive, Frank Karbe, to its Board of Directors
18/04/2019
BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical stage biopharmaceutical company developing therapies in the Stimulator of Interferon Genes (STING) and A Proliferation [...]
Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019
18/04/2019
BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]
SeaSpine to Report First Quarter 2019 Financial Results on May 1, 2019
18/04/2019
CARLSBAD, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Corcept Therapeutics to Present Data at the 2019 American Association of Clinical Endocrinologists’ 28th Annual Congress
18/04/2019
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Intuitive Announces First Quarter Earnings
18/04/2019
SUNNYVALE, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive” or the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted [...]

Pages